首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.
【24h】

Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.

机译:华法林和对乙酰氨基酚的相互作用:证据和生物学合理性的总结。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ms TS is a 66-year-old woman who receives warfarin for prevention of systemic embolization in the setting of hypertension, diabetes, and atrial fibrillation. She had a transient ischemic attack about 4 years ago when she was receiving aspirin. Her INR control was excellent; however, over the past few months it has become erratic, and her average dose required to maintain an INR of 2.0 to 3.0 appears to have decreased. She has had back pain over this same period and has been taking acetaminophen at doses at large as 650 mg four times daily, with her dose varying based on her symptoms. You recall a potential interaction and wonder if (1) her acetaminophen use is contributing to her loss of INR control, and (2) does this interaction place her at increased risk of warfarin-related complications?
机译:TS女士是一位66岁的女性,她服用华法令是为了预防高血压,糖尿病和心房颤动引起的全身栓塞。大约在4年前接受阿司匹林治疗时,她发生了短暂性脑缺血发作。她的INR控制非常好;但是,在过去的几个月中,它变得不固定了,维持INR为2.0至3.0所需的平均剂量似乎有所下降。在同一时期,她背部疼痛,每天服用四次650 mg剂量的对乙酰氨基酚,剂量随症状而变化。您回想起一种潜在的相互作用,并想知道(1)她使用对乙酰氨基酚是否会导致INR控制丧失;(2)这种相互作用是否会使她面临与华法林相关的并发症的风险增加?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号